Open access · OA
via OpenAlex
Nuclear inclusion bodies of mutant and wild‐type p53 in cancer: a hallmark of p53 inactivation and proteostasis remodelling by p53 aggregation
Frederik De Smet, Mirian Saiz Rubio, Daphne Hompes, Evelyne Naus, Greet De Baets, Tobias Langenberg, Mark S. Hipp, Bert Houben, Filip Claes, Sarah Charbonneau, Javier Delgado, Stéphane Plaisance, Shakti Ramkissoon, Lori Ramkissoon, Colinda C.J.M. Simons
The Journal of Pathology · 2016 · ▲ 71 citations
Abstract
Although p53 protein aggregates have been observed in cancer cell lines and tumour tissue, their impact in cancer remains largely unknown. Here, we extensively screened for p53 aggregation phenotypes in tumour biopsies, and identified nuclear inclusion bodies (nIBs) of transcriptionally inactive mutant or wild-type p53 as the most frequent aggregation-like phenotype across six different cancer types. p53-positive nIBs co-stained with nuclear aggregation markers, and shared molecular hallmarks of nIBs commonly found in neurodegenerative disorders. In cell culture, tumour-associated stress was a strong inducer of p53 aggregation and nIB formation. This was most prominent for mutant p53, but could also be observed in wild-type p53 cell lines, for which nIB formation correlated with the loss of p53's transcriptional activity. Importantly, protein aggregation also fuelled the dysregulation of the proteostasis(definition) network in the tumour cell by inducing a hyperactivated, oncogenic heat-shock response, to which tumours are commonly addicted, and by overloading the proteasomal degradation system, an observation that was most pronounced for structurally destabilized mutant p53. Patients showing tumours with p53-positive nIBs suffered from a poor clinical outcome, similar to those with loss of p53 expression, and tumour biopsies showed a differential proteostatic expression profile associated with p53-positive nIBs. p53-positive nIBs therefore highlight a malignant state of the tumour that results from the interplay between (1) the functional inactivation of p53 through mutation and/or aggregation, and (2) microenvironmental stress, a combination that catalyses proteostatic dysregulation. This study highlights several unexpected clinical, biological and therapeutically unexplored parallels between cancer and neurodegeneration. Copyright © 2017 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1002/path.4872
- Canonical
- link ↗
- Fetched
- 2026-06-09 MST
Cite this
APA
Smet, F.D., Rubio, M.S., Hompes, D., Naus, E., Baets, G.D., Langenberg, T., Hipp, M.S., Houben, B., Claes, F., Charbonneau, S., Delgado, J., Plaisance, S., Ramkissoon, S., Ramkissoon, L., Simons, C.C., Brandt, P.A.V.D., Weijenberg, M., England, M.V., Lambrechts, S., & Amant, F. (2016). Nuclear inclusion bodies of mutant and wild‐type p53 in cancer: a hallmark of p53 inactivation and proteostasis remodelling by p53 aggregation. <em>The Journal of Pathology</em>. https://doi.org/10.1002/path.4872
Vancouver
Smet FD, Rubio MS, Hompes D, Naus E, Baets GD, Langenberg T, et al. Nuclear inclusion bodies of mutant and wild‐type p53 in cancer: a hallmark of p53 inactivation and proteostasis remodelling by p53 aggregation. The Journal of Pathology. 2016. doi:10.1002/path.4872.
BibTeX
@article{frederik2016Nuclea,
title = {Nuclear inclusion bodies of mutant and wild‐type p53 in cancer: a hallmark of p53 inactivation and proteostasis remodelling by p53 aggregation},
author = {Frederik De Smet and Mirian Saiz Rubio and Daphne Hompes and Evelyne Naus and Greet De Baets and Tobias Langenberg and Mark S. Hipp and Bert Houben and Filip Claes and Sarah Charbonneau and Javier Delgado and Stéphane Plaisance and Shakti Ramkissoon and Lori Ramkissoon and Colinda C.J.M. Simons and Piet A. van den Brandt and Matty Weijenberg and Manon Van England and Sandrina Lambrechts and Frédéric Amant and André D’Hoore and Keith L. Ligon and Xavier Sagaert and Joost Schymkowitz and Frédéric Rousseau},
journal = {The Journal of Pathology},
year = {2016},
doi = {10.1002/path.4872},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Development 2005
Open access · OA
p53 suppresses the self-renewal of adult neural stem cells
PLoS ONE 2015
Open access · CC-BY
SerpinB2 (PAI-2) Modulates Proteostasis via Binding Misfolded Proteins and Promotion of Cytoprotective Inclusion Formation
Nature 2013
Open access · CC-BY
Mutational landscape and significance across 12 major cancer types
American Journal of Reproductive Immunology 2017
Citation only
Telomere length and fetal programming: A review of recent scientific advances
Frontiers in Cell and Developmental Biology 2016
Open access · CC-BY
The Unfolded Protein Response and the Role of Protein Disulfide Isomerase in Neurodegeneration
Proceedings of the National Academy of Sciences 2005
Preprint · OA